SCHEMBL4064464

SCHEMBL4064464

Cc1ccccc1Oc1ccc(N)cn1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.77
MEN1 O00255 4/20 0.66
KMT2A Q03164 4/20 0.66
SMN1; SMN2 Q16637 3/20 0.59
RAB9A P51151 2/20 0.59
NPC1 O15118 1/20 0.59
TSHR P16473 1/20 0.59
KDM4E B2RXH2 5/20 0.54
POLB P06746 2/20 0.51
MAP4K4 O95819 1/20 0.51
ALDH1A1 P00352 3/20 0.50
BRCA1 P38398 1/20 0.50
HBB P68871 1/20 0.50
HSD17B10 Q99714 1/20 0.50
ALOX5AP P20292 2/20 0.47
FEN1 P39748 2/20 0.47
OXTR P30559 1/20 0.42
HPGD P15428 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1014038 0.87 KEAP1 (1.00) KEAP1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL12593846 0.83 KEAP1 (0.62) KEAP1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL23720003 0.83 MEN1 (0.66) KEAP1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL31683896 0.83 MEN1 (0.66) KEAP1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL4070182 0.81 KEAP1 (0.60) KEAP1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL1979598 0.81 KEAP1 (0.69) KEAP1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL4065605 0.80 KEAP1 (0.59) KEAP1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL7079635 0.80 KEAP1 (0.59) KEAP1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL4070376 0.80 KEAP1 (0.63) KEAP1MEN1KMT2ARAB9AKDM4E
SCHEMBL1978731 0.80 KEAP1 (0.59) KEAP1MEN1KMT2ARAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1028945-B9 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS AMGEN INC (US) 2009-02-18 EP disclosed
EP-1028945-B1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS AMGEN INC (US) 2007-07-11 EP disclosed
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 US disclosed
EP-1028945-A1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS Amgen Inc. (US) 2000-08-23 EP disclosed
WO-1999024404-A1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS AMGEN INC. (US) 1999-05-20 WO disclosed